Join Dr. Louis Mazzarelli as he discusses the uses and benefits of 18F Fluciclovine in today’s prostate imaging landscape. Review current practice techniques, pitfalls, and a look at the future for imaging biochemically recurrent prostate cancer.
Nuclear Medicine
Oncology
Interventional Radiology
Request information
Share
1 / 0
Louis Mazzarelli
Director of Molecular Imaging at Lawrence and Memorial and Westerly Hospitals with Yale New Haven Health, Connecticut, United States
Speaker
Showcased products
1 / 0
PETNET Solutions, Inc.
PETNET Solutions, Inc., a Siemens Healthineers company, supports the growth of our customers' business with on-time delivery of PET tracers and comprehensive value-added services.
Related sessions
1 / 0
55 minWebinar
The changing prostate panorama: 18F-Fluciclovine and its role in biochemically recurrent prostate cancer
Join Dr. Hollie Lai as she discusses challenges associated with PET/CT imaging in pediatric patients. This hour-long webinar provides an in-depth review of the physiologic uptake in areas that differ from imaging adults, how to identify the differences, and what can be done to improve overall image quality when scanning pediatric patients.
Hollie A. Dr. Lai
Nuclear Medicine
Oncology
+ 1
55 minWebinar
The role of FDG PET/CT in the theranostic era
Join Dr. Daniel Pryma as he takes a deep dive into the history, current uses, and the future of theranostics. Learn more about several FDA-approved theranostic pairs and discover the advantages and disadvantages of using this technology to combat life-threatening diseases.
Daniel A. Pyrma
Nuclear Medicine
Oncology
+ 1
Related products and topics
1 / 0
The Value of Molecular Imaging for Prostate Cancer
Molecular imaging plays an important role in the evaluation of prostate cancer and visualizes the extent of disease and biological response to treatment throughout the continuum of care.